BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Approvable Letter
FDA Accepts for Review Theravance, Inc. (THRX)'s Complete Response Submission for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections 4/27/2009 12:09:09 PM    More...
Discovery Laboratories (DSCO) to File Surfaxin Response in 4 Weeks 9/24/2008 8:23:01 AM    More...
Cardiome Pharma Corp. (COM.TO) And Astellas Pharma Inc. Announce Receipt Of FDA Approvable Letter For KYNAPID(TM) 8/11/2008 8:05:10 AM    More...
Discovery Laboratories (DSCO) Reports Progress in Responding to Surfaxin FDA Approvable Letter 8/6/2008 7:30:48 AM    More...
UCB Group (UCBJF.PK) Receives Not-approvable Letter from FDA for Lacosamide for Diabetic Neuropathic Pain 7/29/2008 3:55:01 PM    More...
Eisai Corporation of North America Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures; FDA's Not Approvable Letter Outlines Pathway to Potential Approval 7/28/2008 6:18:24 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA) Announces Receipt of Not Approvable Letter From FDA for Iloperidone 7/28/2008 6:42:20 AM    More...
NexMed (NEXM) Receives FDA Non Approvable Letter for ED Product 7/23/2008 6:31:26 AM    More...
Xanodyne Pharmaceuticals, Inc. Receives Approvable Letter From the U.S. FDA for ZIPSOR(TM) Capsules 7/22/2008 6:29:24 AM    More...
Sciele Pharma, Inc. (SCRX) Announces That the FDA Has Issued an Approvable Letter for the Head Lice Treatment 7/17/2008 6:42:33 AM    More...
FDA (JOBS) Revises Process for Responding to Drug Applications 7/10/2008 6:37:24 AM    More...
Indevus Pharmaceuticals, Inc. (IDEV) Receives Approvable Letter from FDA for NEBIDO(R); Company Announces Revised Operating Plan to Respond to NEBIDO Delay 6/30/2008 8:53:02 AM    More...
Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase) 6/19/2008 6:41:23 AM    More...
Discovery Laboratories (DSCO) Delays Surfaxin Response to FDA 6/19/2008 7:03:32 AM    More...
FDA Requests More Information On Meda AB (SE:MEDAa)'s New Azelastine Formulation 6/4/2008 9:04:51 AM    More...
1234567
 

//-->